Brigham and Women’s Hospital, United States
Disclosure information not submitted.
SW-2G - Addressing the threat of confounding in pharmacoepidemiology with innovative methods: Lessons from the FDA Sentinel Innovation Center
Sunday, August 24, 20255:15 PM - 6:45 PM ET
4G-04 - Temporal High Dimensional Propensity Score (thdPS): A Novel Approach to Improve Confounding Control by Incorporating Temporality to High Dimensional variables
Monday, August 25, 20255:00 PM - 5:15 PM ET
